Astria Therapeutics Inc (ATXS)

12:13 PM

Key metrics from Astria Therapeutics Inc.’s quarterly dataMarket Movement Recap & Daily Profit Focused Stock Screening - Newser

12:13 PM

Sep 06, 2025

What does recent volatility data suggest for Astria Therapeutics Inc.2025 Major Catalysts & Consistent Profit Alerts - Newser

Sep 06, 2025

Sep 06, 2025

Astria Therapeutics, Inc. $ATXS Shares Purchased by Hsbc Holdings PLC - Defense World

Sep 06, 2025

Sep 06, 2025

Is Astria Therapeutics Inc. stock forming a cup and handleJuly 2025 Review & Low Risk High Reward Trade Ideas - خودرو بانک

Sep 06, 2025

Sep 05, 2025

Has Astria Therapeutics Inc. formed a bullish divergence2025 Analyst Calls & Technical Pattern Alert System - Newser

Sep 05, 2025

Sep 05, 2025

Will Astria Therapeutics Inc. outperform its industry peersJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 05, 2025

Sep 05, 2025

Does Astria Therapeutics Inc. have strong EBITDA marginsPortfolio Gains Report & Daily Growth Stock Tips - خودرو بانک

Sep 05, 2025

Sep 05, 2025

What to expect from Astria Therapeutics Inc. in the next 30 daysDividend Hike & Stepwise Trade Execution Plans - Newser

Sep 05, 2025

Sep 05, 2025

Can Astria Therapeutics Inc. maintain its current growth rate2025 Top Gainers & Verified Short-Term Plans - خودرو بانک

Sep 05, 2025

Sep 05, 2025

What machine learning models say about Astria Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser

Sep 05, 2025

Sep 05, 2025

Astria Therapeutics (ATXS): Strategic Advancements and Clinical Catalysts in 2025 Position the Biotech for Strong Shareholder Value - AInvest

Sep 05, 2025

Sep 05, 2025

Astria Therapeutics: A High-Conviction Biotech Play in Rare Diseases and Immune Disorders - AInvest

Sep 05, 2025

Sep 05, 2025

Transcript : Astria Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 03 - MarketScreener

Sep 05, 2025

Sep 05, 2025

Astria Therapeutics Inc. stock daily chart insights2025 Fundamental Recap & Real-Time Market Sentiment Alerts - Newser

Sep 05, 2025

Sep 04, 2025

Does Astria Therapeutics Inc. have pricing power2025 Technical Patterns & Daily Growth Stock Investment Tips - خودرو بانک

Sep 04, 2025

Sep 04, 2025

Astria Therapeutics at Cantor Conference: Strategic Program Insights By Investing.com - Investing.com Canada

Sep 04, 2025

Sep 04, 2025

Astria Therapeutics Inc. stock volume spike explained2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser

Sep 04, 2025

Sep 04, 2025

Astria Therapeutics at Cantor Conference: Strategic Program Insights - Investing.com

Sep 04, 2025

Sep 04, 2025

Astria Therapeutics shares fall 3.58% intraday after announcing inducement grants. - AInvest

Sep 04, 2025

Sep 04, 2025

What machine learning models say about Astria Therapeutics IncSwing Trade & Free Weekly Watchlist of Top Performers - Newser

Sep 04, 2025

Sep 04, 2025

Astria Therapeutics Inc. stock trend forecastPortfolio Profit Report & Fast Gain Swing Alerts - Newser

Sep 04, 2025

Sep 04, 2025

103,517 Shares in Astria Therapeutics, Inc. $ATXS Acquired by Nuveen LLC - Defense World

Sep 04, 2025

Sep 04, 2025

Is Astria Therapeutics Inc. stock poised for growth2025 Performance Recap & Risk Controlled Daily Plans - Newser

Sep 04, 2025

Sep 04, 2025

Detecting support and resistance levels for Astria Therapeutics Inc.Portfolio Return Report & Consistent Income Trade Ideas - Newser

Sep 04, 2025

Sep 03, 2025

Can Astria Therapeutics Inc. expand into new marketsMarket Sentiment Report & Verified Short-Term Plans - خودرو بانک

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics’ Strategic Use of Equity Incentives: A Catalyst for Talent Retention and Innovation in a High-Stakes Biotech Landscape? - AInvest

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics shares rise 3.26% intraday after announcing Phase 1a trial data presentation at EADV Congress 2025. - AInvest

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics to present STAR-0310 phase 1a data at EADV congress - Investing.com

Sep 03, 2025

Sep 03, 2025

Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025 - Yahoo Finance

Sep 03, 2025

Sep 03, 2025

Can Astria Therapeutics Inc. disrupt its industryCEO Change & Fast Exit Strategy with Risk Control - khodrobank.com

Sep 03, 2025

Sep 03, 2025

Trading Recap: Is Astria Therapeutics Inc. in a bullish channelBull Run & Safe Capital Growth Tips - خودرو بانک

Sep 03, 2025

Sep 03, 2025

Technical analysis overview for Astria Therapeutics Inc. stockJuly 2025 Setups & Verified Technical Signals - Newser

Sep 03, 2025

Sep 03, 2025

Visual trend scoring systems applied to Astria Therapeutics Inc.2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser

Sep 03, 2025

Sep 02, 2025

Is Astria Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser

Sep 02, 2025

Sep 02, 2025

Astria Therapeutics, Inc. $ATXS Shares Purchased by Wellington Management Group LLP - Defense World

Sep 02, 2025

Sep 01, 2025

What earnings revisions data tells us about Astria Therapeutics Inc.July 2025 Outlook & Real-Time Stock Price Movement Reports - Newser

Sep 01, 2025

Sep 01, 2025

Charles Schwab Investment Management Inc. Sells 7,560 Shares of Astria Therapeutics, Inc. $ATXS - Defense World

Sep 01, 2025

Aug 31, 2025

Visual trend scoring systems applied to Astria Therapeutics IncWall Street Watch & Weekly Top Gainers Trade List - Newser

Aug 31, 2025

Aug 31, 2025

Applying Elliott Wave Theory to Astria Therapeutics Inc.Market Performance Report & High Accuracy Trade Alerts - Newser

Aug 31, 2025